Autopsy report · NCT01402219

Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients

“There were few eligible subjects from other centers.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 8 months after it had already started.
• Ran for about 4 years 6 months before it stopped.
• 204 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Guangdong Provincial People's Hospital

Sponsor type

University, hospital or other

Conditions

Chronic Renal Disease

Interventions

Iopamidol injection 76%; iodixanol

Participants

204

Sites

1

Countries

China

Trials that died the same way

• Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
  “Lack of eligible subjects.” (73% match in meaning)
• Sirolimus for the Treatment of Hyperinsulinism
  “Due to strict inclusion and exclusion criteria no subjects were enrolled” (71% match in meaning)
• Safety Study of Autologous Cultured Adipose -Derived Stem Cells for the Fecal Incontinence
  “Few subject enrolled” (68% match in meaning)
• Characterization of a Clinical Subpopulation in Children With Autism Spectrum Disorder
  “No subjects enrolled” (67% match in meaning)
• Home Study of Subjects Who Have Completed a Previous Continuous Negative External Pressure (cNEP) Clinical Trial
  “no eligible subjects were available for recruitment” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.